CSIMarket
 


Cara Therapeutics inc   (CARA)
Other Ticker:  
 
 

CARA's Free Cash Flow Growth by Quarter and Year

Cara Therapeutics Inc 's Free Cash Flow results by quarter and year




CARA Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -17.37 -23.51 -14.12 -21.62
III Quarter September -19.65 -25.19 -21.01 -27.65
II Quarter June -20.45 -4.50 -23.72 -38.30
I Quarter March -34.62 -25.53 82.09 -31.17
FY   -92.09 -78.73 23.24 -118.74



CARA Free Cash Flow fourth quarter 2023 Y/Y Growth Comment
Cara Therapeutics inc in the fourth quarter 2023 recorded free cash outflow of $ -17.37 millions.

According to the results reported in the fourth quarter 2023, Cara Therapeutics Inc achieved the best Free Cash Flow growth in Major Pharmaceutical Preparations industry. While Cara Therapeutics Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the fourth quarter 2023.




CARA Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Cara Therapeutics Inc 's fourth quarter 2023 Free Cash Flow $ -17.37 millions CARA's Income Statement
Cara Therapeutics Inc 's fourth quarter 2022 Free Cash Flow $ -23.51 millions Quarterly CARA's Income Statement
New: More CARA's historic Free Cash Flow Growth >>


CARA Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Cara Therapeutics Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CARA's IV. Quarter Q/Q Free Cash Flow Comment
Despite the fact, that Cara Therapeutics inc in the IV. Quarter 2023 showed free cash outflow of $ -17.37 millions, some analyst point out, that current results are recovery compare to the -19.65 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Cara Therapeutics inc achieved highest sequential Free Cash Flow growth. While Cara Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CARA's IV. Quarter Q/Q Free Cash Flow Comment
Even if Cara Therapeutics inc in the IV. Quarter 2023 showed free cash outflow of $ -17.37 millions, it should be mentioned, that current results are improvement in contrast to the -19.65 millions in the third quarter.

Within Major Pharmaceutical Preparations industry Cara Therapeutics inc achieved highest sequential Free Cash Flow growth. While Cara Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Cara Therapeutics Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Free Cash Flow 12 Months Ending $ -92.08 $ -98.22 $ -103.77 $ -87.82 $ -78.73
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Cara Therapeutics Inc ' has realized cumulative trailing twelve months free cash outflow of $ -92 millions in the Dec 31 2023 period.

Cara Therapeutics inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
Cara Therapeutics Inc ' has realized cumulative trailing twelve months free cash outflow of $ -92 millions in the Dec 31 2023 period.

Cara Therapeutics inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
CARA's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for CARA's Competitors
Free Cash Flow Growth for Cara Therapeutics Inc 's Suppliers
Free Cash Flow Growth for CARA's Customers

You may also want to know
CARA's Annual Growth Rates CARA's Profitability Ratios CARA's Asset Turnover Ratio CARA's Dividend Growth
CARA's Roe CARA's Valuation Ratios CARA's Financial Strength Ratios CARA's Dividend Payout Ratio
CARA's Roa CARA's Inventory Turnover Ratio CARA's Growth Rates CARA's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Dec 31 2023
Sanofi-2.55%$ -2.546 millions
Inmode Ltd -2.62%$ -2.617 millions
Charles River Laboratories International inc -5.88%$ -5.884 millions
Mettler toledo International Inc -7.29%$ -7.291 millions
Envista Holdings Corporation-7.52%$ -7.525 millions
Bio rad Laboratories Inc -10.37%$ -10.366 millions
Inspire Medical Systems inc -10.39%$ -10.390 millions
Insulet Corporation-10.85%$ -10.848 millions
Laboratory Corporation Of America Holdings-11.32%$ -11.322 millions
Hologic Inc-13.18%$ -13.181 millions
Neurocrine Biosciences Inc -13.64%$ -13.636 millions
Gilead Sciences Inc -15.50%$ -15.504 millions
Bausch Health Companies Inc -17.89%$ -17.895 millions
Koru Medical Systems Inc-17.93%$ -17.932 millions
Progyny Inc -26.90%$ -26.900 millions
Ufp Technologies Inc -29.00%$ -28.997 millions
Enhabit Inc -29.27%$ -29.268 millions
Integra Lifesciences Holdings Corp-31.15%$ -31.153 millions
Cryoport inc -32.07%$ -32.074 millions
Qiagen N v -35.76%$ -35.764 millions
Abbvie inc -36.01%$ -36.012 millions
Regeneron Pharmaceuticals Inc -36.64%$ -36.642 millions
Pfizer Inc-38.94%$ -38.942 millions
Axonics Inc -39.81%$ -39.805 millions
Warby Parker Inc -42.68%$ -42.678 millions
Catalent Inc -47.66%$ -47.664 millions
Intuitive Surgical Inc -47.86%$ -47.865 millions
Incyte Corporation-47.92%$ -47.921 millions
Jazz Pharmaceuticals Plc-51.07%$ -51.066 millions
Edwards Lifesciences Corporation-51.70%$ -51.697 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com